Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Fennec Pharmaceuticals Ownership Summary

Fennec Pharmaceuticals is owned by 54.55% institutional investors, 16.22% insiders, and 29.23% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 15.08% of FENC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Fennec Pharmaceuticals	54.55%	16.22%	29.23%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Southpoint capital advisors lp	4.08M	15.08%	$24.91M
Sonic gp	2.41M	8.90%	$14.71M
Dg capital management	1.63M	6.04%	$9.99M
Solas capital management	1.34M	4.95%	$8.19M
Blackrock	1.19M	4.39%	$7.25M
Vanguard group	1.03M	3.80%	$6.27M
Harbert fund advisors	466.87K	1.73%	$2.85M
State street	321.21K	1.19%	$1.96M
Geode capital management	301.58K	1.12%	$1.84M
Gendell jeffrey l	283.37K	1.05%	$1.73M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sonic gp	2.41M	30.37%	$14.71M
Solas capital management	1.34M	4.48%	$8.19M
Dg capital management	1.63M	3.85%	$9.99M
Harbert fund advisors	466.87K	2.03%	$2.85M
Lion point capital, lp	170.00K	1.89%	$1.04M
Southpoint capital advisors lp	4.08M	0.62%	$24.91M
Hartford financial management	48.85K	0.06%	$298.46K
Gendell jeffrey l	283.37K	0.06%	$1.73M
Wexford capital lp	26.41K	0.04%	$161.39K
Sherbrooke park advisers	28.37K	0.03%	$173.34K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.19M	0.00%	259.78K
Solas capital management	1.34M	4.48%	229.77K
Dg capital management	1.63M	3.85%	123.15K
Geode capital management	301.58K	0.00%	81.82K
Winton group	67.00K	0.03%	67.00K

Top Sellers

Holder	Shares	% Assets	Change
Aigh capital management	-	-	-570.33K
Essex investment management	-	-	-144.22K
Renaissance	-	-	-139.90K
Legato capital management	-	-	-57.12K
683 capital management	-	-	-48.11K

New Positions

Holder	Shares	% Assets	Change	Value
Winton group	67.00K	0.03%	67.00K	$409.40K
Verition fund management	33.74K	0.00%	33.74K	$206.14K
Sherbrooke park advisers	28.37K	0.03%	28.37K	$173.34K
State of wisconsin investment board	13.03K	0.00%	13.03K	$79.64K
Corebridge financial	12.61K	0.00%	12.61K	$77.05K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-3.00
Toronto dominion bank	-25.00
Cornerstone planning group	-66.00
Citadel advisors	-100.00
Point72 (difc)	-256.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	62	-	14,931,284	3.97%	54	1.93%	33	-19.51%	15	36.36%
Jun 30, 2024	62	-7.46%	14,360,529	-0.88%	53	1.82%	41	13.89%	11	-42.11%
Mar 31, 2024	67	15.52%	14,487,913	-3.48%	53	1.68%	36	24.14%	19	35.71%
Dec 31, 2023	58	-1.69%	15,010,968	4.85%	56	1.94%	29	45.00%	14	-17.65%
Sep 30, 2023	59	-1.67%	14,316,429	1.60%	54	1.92%	20	-45.95%	17	41.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	876.21K	3.20%	-
iShares Russell 2000 ETF	559.37K	2.04%	-1.26K
Fidelity Small Cap Index	241.02K	0.88%	-4.65K
iShares Russell 2000 Value ETF	165.51K	0.60%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	122.70K	0.45%	-
Vanguard Russell 2000 ETF	107.20K	0.39%	-680.00
State St Russell Sm Cap® Indx SL Cl I	69.00K	0.25%	-
NT R2000 Index Fund - NL	57.45K	0.21%	16.89K
Schwab Small Cap Index	55.45K	0.20%	-
iShares Micro-Cap ETF	53.29K	0.19%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 05, 2024	Raykov Rosty	-	Sell	$4.81K
Dec 03, 2024	Raykov Rosty	-	Sell	$10.02K
Dec 02, 2024	RALLIS CHRIS A	-	Sell	$39.35K
Nov 04, 2024	Raykov Rosty	-	Sell	$10.48K
Oct 08, 2024	RALLIS CHRIS A	-	Sell	$6.37K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2024 Q4	-	1
2024 Q3	-	4
2024 Q2	2	18
2024 Q1	-	5

FENC Ownership FAQ

Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 54.55%, followed by 16.22% insiders and 29.23% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Fennec Pharmaceuticals exceeds.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 15.08%), Sonic gp (2.41M shares, 8.90%), and Dg capital management (1.63M shares, 6.04%). Together, they hold 30.02% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 30.37% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 14.71M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 876.21K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools